University of Vermont

Office of Health Promotion Research

OHPR 2010-2011 Publications

Publications 2010-2016

Berkman A, F Cole B, Ades PA, Dickey S, Higgins ST, Trentham-Dietz A, Sprague BL, Lakoski SG. Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2014 Oct 18. [Epub ahead of print] PubMed PMID:

Bolton KC, Mace JL, Vacek PM, Herschorn SD, James TA, Tice JA, Kerlikowske K, Geller BM, Weaver DL, Sprague BL. Changes in breast cancer risk distribution among Vermont women using screening mammography. J Natl Cancer Inst. 2014 Jun 23;106(8). pii: dju157. doi: 10.1093/jnci/dju157. Print 2014 Aug. PubMed PMID: 24957223.

Carney PA, Aiello Bowles EJ, Sickles EA, Geller BM, Feig SA, Jackson S, Brown D, Cook A, Yankaskas BC, Miglioretti DL, Elmore JG. Using a Tailored Web-based Intervention to Set Goals to Reduce Unnecessary Recall. Acad Radiol. 2011 Apr;18(4):495-503. Epub 2011 Jan 20.

Dulko D, Pace CM, Dittus KL, Sprague BL, Pollack LA, Hawkins NA, Geller BM. Barriers and facilitators to implementing cancer survivorship care plans. Oncol Nurs Forum. 2013 Nov;40(6):575-80. doi: 10.1188/13.ONF.575-580. PubMed PMID:

Fenton JJ, Onega T, Zhu W, Balch S, Smith-Bindman R, Henderson L, Sprague BL, Kerlikowske K, Hubbard RA. Validation of a Medicare Claims-based Algorithm for Identifying Breast Cancers Detected at Screening Mammography. Med Care. 2013 Aug
6. [Epub ahead of print] PubMed PMID: 23929404; PubMed Central PMCID: PMC3865072.

Houssami N, Abraham LA, Onega T, Collins LC, Sprague BL, Hill DA, Miglioretti DL. Accuracy of screening mammography in women with a history of lobular carcinoma in situ or atypical hyperplasia of the breast. Breast Cancer Res Treat.
2014 Jun;145(3):765-73. doi: 10.1007/s10549-014-2965-z. Epub 2014 May 7. PubMed PMID: 24800915; PubMed Central PMCID: PMC4111461.

Hubbard RA, Zhu W, Horblyuk R, Karliner L, Sprague BL, Henderson L, Lee D, Onega T, Buist DS, Sweet A. Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography. Breast Cancer Res Treat. 2013 Apr;138(3):879-87. doi: 10.1007/s10549-013-2466-5. Epub 2013 Mar 8. PubMed PMID: 23471650; PubMed Central PMCID: PMC3640408.

Jewett PI, Gangnon RE, Trentham-Dietz A, Sprague BL. Trends of postmenopausal estrogen plus progestin prevalence in the United States between 1970 and 2010. Obstet Gynecol. 2014 Oct;124(4):727-33. doi: 10.1097/AOG.0000000000000469. PubMed PMID: 25198271; PubMed Central PMCID: PMC4172523.

Lee CI, Ichikawa L, Rochelle MC, Kerlikowske K, Miglioretti DL, Sprague BL, DeMartini WB, Wernli KJ, Joe BN, Yankaskas BC, Lehman CD. Breast MRI BI-RADS Assessments and Abnormal Interpretation Rates by Clinical Indication in US Community Practices. Acad Radiol. 2014 Nov;21(11):1370-6. doi: 10.1016/j.acra.2014.06.003. Epub 2014 Aug 7. PubMed PMID: 25126973; PubMed Central PMCID: PMC4194166.

McLaughlin VH, Trentham-Dietz A, Hampton JM, Newcomb PA, Sprague BL. Lifestyle factors and the risk of a second breast cancer after ductal carcinoma in situ. Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):450-60. doi: 10.1158/1055-9965.EPI-13-0899. Epub 2014 Jan 8. PubMed PMID: 24403528; PubMed Central PMCID: PMC3951673.

Munoz D, Near AM, van Ravesteyn NT, Lee SJ, Schechter CB, Alagoz O, Berry DA, Burnside ES, Chang Y, Chisholm G, de Koning HJ, Ali Ergun M, Heijnsdijk EA, Huang H, Stout NK, Sprague BL, Trentham-Dietz A, Mandelblatt JS, Plevritis SK. Effects of Screening and Systemic Adjuvant Therapy on ER-Specific US Breast Cancer Mortality. J Natl Cancer Inst. 2014 Sep 24;106(11). pii: dju289. doi: 10.1093/jnci/dju289. Print 2014 Nov. PubMed PMID: 25255803.

Munsell MF, Sprague BL, Berry DA, Chisholm G, Trentham-Dietz A. Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev. 2014;36(1):114-36. doi: 10.1093/epirev/mxt010. Review. PubMed PMID: 24375928; PubMed Central PMCID: PMC3873844.

Onega T, Beaber EF, Sprague BL, Barlow WE, Haas JS, Tosteson AN, D Schnall M, Armstrong K, Schapira MM, Geller B, Weaver DL, Conant EF. Breast cancer screening in an era of personalized regimens: A conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level. Cancer. 2014 Oct 1;120(19):2955-64. doi: 10.1002/cncr.28771. Epub 2014 May 15. PubMed PMID: 24830599.

Scheel JR, Lee JM, Sprague BL, Lee CI, Lehman CD. Screening ultrasound as an adjunct to mammography in women with mammographically dense breasts. Am J Obstet Gynecol. 2014 Jun 21. pii: S0002-9378(14)00628-0. doi: 10.1016/j.ajog.2014.06.048. [Epub ahead of print] Review. PubMed PMID: 24959654.

Sprague BL, Bolton KC, Mace JL, Herschorn SD, James TA, Vacek PM, Weaver DL, Geller BM. Registry-based study of trends in breast cancer screening mammography before and after the 2009 U.S. Preventive Services Task Force recommendations.
Radiology. 2014 Feb;270(2):354-61. doi: 10.1148/radiol.13131063. Epub 2013 Oct 28. PubMed PMID: 24072778; PubMed Central PMCID: PMC4118300.

Sprague BL, Dittus KL, Pace CM, Dulko D, Pollack LA, Hawkins NA, Geller BM. Patient satisfaction with breast and colorectal cancer survivorship care plans. Clin J Oncol Nurs. 2013 Jun;17(3):266-72. doi: 10.1188/13.CJON.17-03AP. PubMed PMID: 23722604.

Sprague BL, Gangnon RE, Burt V, Trentham-Dietz A, Hampton JM, Wellman RD, Kerlikowske K, Miglioretti DL. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst. 2014 Sep 12;106(10). pii: dju255. doi: 10.1093/jnci/dju255. Print 2014 Oct. PubMed PMID: 25217577.

Sprague BL, McLaughlin V, Hampton JM, Newcomb PA, Trentham-Dietz A. Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study. Breast Cancer Res Treat. 2013 Aug;141(1):145-54. doi: 10.1007/ s10549-013-2670-3. Epub 2013 Aug 25. PubMed PMID: 23979007; PubMed Central PMCID: PMC3915783.

Sprague BL, Trentham-Dietz A, Hedman CJ, Wang J, Hemming JD, Hampton JM, Buist DS, Aiello Bowles EJ, Sisney GS, Burnside ES. Circulating serum xenoestrogens and mammographic breast density. Breast Cancer Res. 2013 May 27;15(3):R45. doi: 10.1186/bcr3432. PubMed PMID: 23710608; PubMed Central PMCID: PMC4053153.

Trentham-Dietz A, Sprague BL, Hampton JM, Miglioretti DL, Nelson HD, Titus LJ, Egan KM, Remington PL, Newcomb PA. Modification of breast cancer risk according to age and menopausal status: a combined analysis of five
population-based case-control studies. Breast Cancer Res Treat. 2014 May;145(1):165-75. doi: 10.1007/s10549-014-2905-y. Epub 2014 Mar 20. PubMed PMID: 24647890; PubMed Central PMCID: PMC4112552.

Wang J, Trentham-Dietz A, Hemming JD, Hedman CJ, Sprague BL. Serum factors and clinical characteristics associated with serum E-screen activity. Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):962-71. doi: 10.1158/1055-9965.EPI-12-1117. Epub 2013 Apr 15. PubMed PMID: 23588007; PubMed Central PMCID: PMC3726048.

Wernli KJ, O'Meara ES, Kerlikowske K, Miglioretti DL, Muller CY, Onega T, Sprague BL, Henderson LM, Buist DS. Investigation of mammographic breast density as a risk factor for ovarian cancer. J Natl Cancer Inst. 2014 Jan;106(1):djt341. doi: 10.1093/jnci/djt341. Epub 2013 Dec 5. PubMed PMID: 24309005; PubMed Central PMCID: PMC3906993.


Last modified July 13 2016 04:29 PM

Contact UVM © 2017 The University of Vermont - Burlington, VT 05405 - (802) 656-3131